All Stories

  1. Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Article • Kidney International, March 2026, Elsevier

    Jürgen Floege

  2. Corrigendum to “Treatment of patients with IgA nephropathy: a call for a new paradigm.” Kidney International 2025;107:640–651

    Article • Kidney International, December 2025, Elsevier

    Jürgen Floege

  3. Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)

    Article • Kidney International, October 2025, Elsevier

    Jürgen Floege

  4. Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy

    Article • Kidney International, October 2025, Elsevier

    Jürgen Floege

  5. Treatment of patients with IgA nephropathy: a call for a new paradigm

    Article • Kidney International, April 2025, Elsevier

    Jürgen Floege

  6. How I Treat IgA Nephropathy

    Article • Clinical Journal of the American Society of Nephrology, June 2022, American Society of Nephrology

    Jürgen Floege

  7. Fatal Attraction: Immunoglobulin A and the Glomerular Mesangium

    Article • Journal of the American Society of Nephrology, June 2019, American Society of Nephrology

    Jürgen Floege

  8. Magnesium Concentration in Dialysate: Is Higher Better?

    Article • Clinical Journal of the American Society of Nephrology, August 2018, American Society of Nephrology

    Jürgen Floege

  9. Sucroferric oxyhydroxide for the treatment of hyperphosphatemia

    Article • Expert Opinion on Pharmacotherapy, July 2018, Taylor & Francis

    stuart Sprague, Jürgen Floege

  10. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy

    Article • Journal of the American Society of Nephrology, October 2017, American Society of Nephrology

    Jürgen Floege

  11. YB-1 orchestrates onset and resolution of renal inflammation via IL10 gene regulation

    Article • Journal of Cellular and Molecular Medicine, June 2017, Wiley

    Jürgen Floege

  12. Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial

    Article • Clinical Journal of the American Society of Nephrology, December 2015, American Society of Nephrology

    Jürgen Floege, Prof. Dr. Christian Heiss

  13. Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis

    Article • Clinical Journal of the American Society of Nephrology, November 2015, American Society of Nephrology

    Dr Geoffrey A Block, Dr Tilman B. Drueke, Ricardo Correa-Rotter, Dr Gerard M LONDON, Jürgen Floege

  14. The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial

    Article • Clinical Journal of the American Society of Nephrology, April 2015, American Society of Nephrology

    Jürgen Floege

  15. The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial

    Article • Clinical Journal of the American Society of Nephrology, February 2015, American Society of Nephrology

    Dr Geoffrey A Block, Dr Tilman B. Drueke, Ricardo Correa-Rotter, Dr Gerard M LONDON, Jürgen Floege, MD, PhD Aleix Cases

  16. Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4

    Article • Clinical Journal of the American Society of Nephrology, March 2014, American Society of Nephrology

    Jürgen Floege

  17. Influence of Body Mass Index on the Association of Weight Changes with Mortality in Hemodialysis Patients

    Article • Clinical Journal of the American Society of Nephrology, September 2013, American Society of Nephrology

    Dr Drasko Pavlovic, Prof. Carmine Zoccali, Prof. Aníbal A Ferreira, Dr Gerard M LONDON, dr Dierik L Verbeelen, Jürgen Floege, Nagy Judit, Prof.dr.sc. Drasko Pavlovic